Anhui Huaheng Biotechnology Co., Ltd. (SHA:688639)

China · Delayed Price · Currency is CNY

17.50

+1.64 (10.34%)

Jul 15, 2026, 3:00 PM CST

-46.87% (1Y)

Market Cap	3.96B -50.6%
Revenue (ttm)	2.95B +24.6%
Net Income	123.41M -19.9%
EPS	0.50 -24.6%
Shares Out	249.40M
PE Ratio	31.85
Forward PE	12.39
Dividend	0.16 (1.01%)
Ex-Dividend Date	May 12, 2026

Volume	10,638,914
Open	15.97
Previous Close	15.86
Day's Range	15.78 - 17.70
52-Week Range	14.52 - 43.60
Beta	0.09
Analysts	Strong Buy
Price Target	45.25 (+158.57%)
Earnings Date	Aug 25, 2026

About SHA:688639

Anhui Huaheng Biotechnology Co., Ltd. engages in the research and development, production, and sale of bio-based products through bio-manufacturing in China and internationally. The company offers amino acid products, including the alanine series, L-valine, isoleucine, tryptophan, and arginine; vitamin products, such as D-calcium pantothenate, D-panthenol, and inositol; bio-based new material monomers, including 1,3-propanediol and succinic acid; and other products, including malic acid and arbutin. Its products are used in daily chemical produ... [Read more]

Industry Biotechnology

Sector Healthcare

Founded 2005

Employees 2,252

Stock Exchange Shanghai Stock Exchange

Ticker Symbol 688639

Full Company Profile

Financial Performance

In 2025, SHA:688639's revenue was 2.86 billion, an increase of 31.40% compared to the previous year's 2.18 billion. Earnings were 132.41 million, a decrease of -30.13%.

Financial Statements

Analyst Summary

According to 2 analysts, the average rating for 688639 stock is "Strong Buy." The 12-month stock price target is ¥45.25, which is an increase of 158.57% from the latest price.

Price Target

¥45.25

(158.57% upside)

Analyst Consensus: Strong Buy

Stock Forecasts